Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Colorcon
McKinsey

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Pharmacia Upjohn Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PHARMACIA UPJOHN, and what generic and branded alternatives to PHARMACIA UPJOHN drugs are available?

PHARMACIA UPJOHN has two approved drugs.



Summary for Pharmacia Upjohn
US Patents:0
Tradenames:2
Ingredients:1
NDAs:2

Drugs and US Patents for Pharmacia Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No   Start Trial   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes   Start Trial   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Pharmacia Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 3,692,895   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 5,490,987   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 3,692,895   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for PHARMACIA UPJOHN drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 g ➤ Subscribe 2005-08-23
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Baxter
AstraZeneca
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.